CLINICAL_TRIALS
trial_result
· 2022-07-11
Clinical Trial Update: Mirabegron Combined With Behavioral Intervention for Overactive Bladder:a Prospective Multicenter Randomized Controlled Clinical Study [Phase 4]
Summary
Prospective multicenter randomized controlled Phase 4 trial evaluating mirabegron combined with behavioral intervention for overactive bladder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Overactive Bladder | Phase 4 | Status: UNKNOWN